oxazoles has been researched along with Edema in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (39.39) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 12 (36.36) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, G; Singh, NP | 1 |
| Chen, H; Chen, Q; Kuang, X; Li, Y; Lu, C; Qiu, Y; Ren, J; Zhou, P | 1 |
| Cho, YS; Suh, JH; Yum, EK | 1 |
| Khanum, NF; Khanum, SA; Shashikanth, M | 1 |
| Achanzar, W; Cheng, P; Cosma, G; Delmonte, T; Dracopoli, NC; Geese, WJ; Hariharan, N; Hui, L; Krishnan, B; Ordway, N; Ranade, K; Rubin, C; Tomlinson, L | 1 |
| Chaturvedi, SC; Pancholi, SS; Sharma, RN; Vasu, KK; Xavier, FP | 1 |
| Al-Khrasani, M; Gyires, K; Mátyus, P; Mózes, MM; Pap, B; Shujaa, N; Zádori, ZS | 1 |
| Fiedorek, FT; Rubin, CJ; Viraswami-Appanna, K | 1 |
| Amat, M; Banoglu, E; Caturla, JF; Kupeli, E; Okçelik, B; Sahin, MF; Unlü, S; Yeşilada, E | 1 |
| Gulcan, HO; Kupeli, E; Sahin, MF; Unlu, S; Yesilada, E | 1 |
| Bansal, VS; Bora, RS; Gupta, A; Khanna, V; Khattar, SK; Mittra, S; Priyadarsiny, P; Roy, S; Saini, KS; Sangle, G; Sattigeri, J; Sharma, L; Sharma, S; Tandon, R | 1 |
| Hong, G; Hughes, A; Lin, X; McCarthy, A; McCarthy, L; Mosteller, M; Sathe, G; Smart, D; Spraggs, C; Traini, C; Van Horn, S; Warren, L | 1 |
| Ahmed, AA; Albert, DH; Bouska, JJ; Bousquet, PF; Cunha, GA; Davidsen, SK; Diaz, G; Glaser, KB; Guo, J; Harris, CM; Ji, Z; Li, J; Marcotte, PA; Michaelides, MR; Moskey, MD; Oie, T; Pease, L; Soni, NB; Stewart, KD | 1 |
| Blasi, ER; Ecelbarger, CM; Heyen, JR; McHarg, AD; Tiwari, S | 1 |
| Aytermir, MD; Demirdamar, R; Erol, DD; Gümüsel, B | 1 |
| Masaki, M; Matsushita, M; Tanaka, T; Wakitani, K; Yagi, Y | 1 |
| Bornemeier, DA; Chan, K; Connor, DT; Doubleday, R; Dyer, RD; Gilbertsen, RB; Guglietta, A; Roth, BD; Schrier, DJ; Sercel, AD; Song, Y; Sorenson, RJ; Unangst, PC | 1 |
| Iwamura, H; Matsushita, M; Tazaki, H; Wakitani, K | 1 |
| Diamantis, W; Ludwig, BJ; Sofia, RD | 2 |
| Saunders, JC; Williamson, WR | 1 |
| Dunwell, DW; Evans, D; Hicks, TA | 1 |
| Miyake, H; Ono, N; Sunami, A; Yamamoto, N; Yamasaki, Y | 1 |
| Bouclier, M; Burg, G; Cavey, D; Delamadeleine, F; Hensby, CN | 1 |
| Georgiev, VS; Mullen, GB; Swift, PA | 1 |
| Bajardi, ML; Daidone, G; Plescia, S; Raffa, D | 1 |
| Friedlander, RL | 1 |
| Begany, AJ; Datko, SL; Dervinis, A; Gluckman, MI; Malis, JL; Rosenthale, ME; Shriver, DA | 1 |
| Berger, FM; Diamantis, W; Douglas, JF; Edelson, J; Gordon, R; Kletzkin, M; Singer, H; Sofia, RD | 1 |
| Alphin, RS; DaVanzo, JP; Funderburk, WH; Helsley, GC; Taylor, CR; Turnbull, LB; Welstead, WJ | 1 |
| Borrelli, F; Caprino, L; Falchetti, R | 1 |
| Crank, G; Foulis, MJ | 1 |
| Brown, K; Cavalla, JF; Green, D; Wilson, AB | 1 |
3 trial(s) available for oxazoles and Edema
| Article | Year |
|---|---|
Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists.
Topics: Animals; Diabetes Mellitus, Type 2; Edema; Endothelin-1; Female; Gene Expression Regulation; Glycine; Humans; Macaca fascicularis; Male; Oxazoles; Pharmacogenetics; Polymorphism, Single Nucleotide; PPAR gamma; Regression Analysis; Renin | 2008 |
Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Edema; Female; Glycated Hemoglobin; Glycine; Humans; Hypoglycemic Agents; Insulin; Lipids; Male; Middle Aged; Oxazoles; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Time Factors; Treatment Outcome; Weight Gain | 2009 |
Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar.
Topics: Adult; Aged; Base Sequence; Diabetes Mellitus, Type 2; DNA Primers; Edema; Epithelial Sodium Channels; Female; Genes, Reporter; Genetic Variation; Humans; Male; Middle Aged; Oxazoles; Pharmacogenetics; Phenotype; PPAR gamma; Promoter Regions, Genetic; Risk Factors; Time Factors; Tyrosine | 2007 |
30 other study(ies) available for oxazoles and Edema
| Article | Year |
|---|---|
Synthesis, anti-inflammatory and analgesic evaluation of thiazole/oxazole substituted benzothiazole derivatives.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Benzothiazoles; Edema; Mice; Molecular Conformation; Oxazoles; Pain; Rats; Structure-Activity Relationship; Thiazoles | 2021 |
Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
Topics: Acute Lung Injury; Amidohydrolases; Animals; Anti-Inflammatory Agents; Cells, Cultured; Edema; Enzyme Inhibitors; Lipopolysaccharides; Macrophages, Alveolar; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Oxazoles; Tetradecanoylphorbol Acetate | 2018 |
Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors.
Topics: Amines; Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Line; Ear; Edema; Humans; Inflammation; Lipoxygenase Inhibitors; Mice; Oxazoles; Structure-Activity Relationship | 2015 |
Synthesis and anti-inflammatory activity of 2-aryloxy methyl oxazolines.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chemistry, Pharmaceutical; Drug Design; Edema; Ethanolamine; Microsomes; Microwaves; Models, Chemical; Oxazoles; Phenylbutazone; Prostaglandin-Endoperoxide Synthases; Rats; Ulcer | 2008 |
Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Benzyl Compounds; Carrageenan; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Hindlimb; Male; Oxazoles; Plethysmography; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Thiazolidines | 2009 |
Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Clonidine; Disease Models, Animal; Edema; Gastrointestinal Motility; Hyperalgesia; Male; Oxazoles; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Rilmenidine; Stomach Ulcer | 2009 |
Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds.
Topics: Acetates; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Humans; In Vitro Techniques; Isoenzymes; Lethal Dose 50; Male; Membrane Proteins; Mice; Oxazoles; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Stomach Ulcer; Structure-Activity Relationship | 2003 |
4-(5-chloro-2(3H)-benzoxazolon-3-yl) butanoic acid derivatives: synthesis, antinociceptive and anti-inflammatory properties.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Disease Models, Animal; Edema; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Oxazoles; Pain; Structure-Activity Relationship | 2003 |
Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Blood Glucose; Body Weight; Cell Differentiation; Edema; Epithelial Sodium Channels; Erythrocyte Count; Fatty Acids; Glycine; Hemoglobins; Kidney; Mice; Mice, Inbred Strains; Oxazoles; PPAR alpha; PPAR gamma; RNA, Messenger; Rosiglitazone; Sodium; Sodium-Potassium-Exchanging ATPase; Thiazolidinediones; Transcriptional Activation | 2007 |
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Binding Sites; Biological Availability; Capillary Permeability; Cell Line; Cell Line, Tumor; Edema; Female; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Models, Molecular; NIH 3T3 Cells; Oxazoles; Phenylurea Compounds; Phosphorylation; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Structure-Activity Relationship; Uterus; Xenograft Model Antitumor Assays | 2008 |
Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats.
Topics: Adiponectin; Animals; Aquaporin 2; Blood Pressure; Edema; Epithelial Sodium Channels; Insulin; Kidney; Male; Natriuresis; Oxazoles; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Triazoles; Water-Electrolyte Balance | 2008 |
Synthesis of ethanone and ethanol derivatives of 2-benzoxazolinone; potent analgesic and antiinflammatory compounds inhibiting prostaglandin E2.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Edema; Ethanol; Female; Magnetic Resonance Spectroscopy; Mice; Oxazoles; Pain Measurement; Prostaglandin Antagonists; Stomach Ulcer | 1995 |
Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzenesulfonates; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hyperalgesia; Indomethacin; Isoenzymes; Male; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar | 1997 |
Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Gastric Mucosa; Humans; Hyperalgesia; Isoenzymes; Male; Membrane Proteins; Mice; Oxazoles; Phenols; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship; Thiazoles | 1999 |
JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
Topics: Animals; Benzenesulfonates; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Edema; Foot; Gastric Mucosa; Inflammation; Isoenzymes; Macrophages, Peritoneal; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Sprague-Dawley; Thromboxane B2 | 2000 |
Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Body Temperature; Dextropropoxyphene; Drug Interactions; Drug Tolerance; Edema; Fever; Humans; Injections, Intravenous; Isoxazoles; Lethal Dose 50; Male; Mice; Narcotic Antagonists; Oxazoles; Quinazolines; Rats; Substance-Related Disorders; Time Factors | 1977 |
Potential antiinflammatory compounds. 2. Acidic antiinflammatory 1,2-benzisoxazoles.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Edema; Isoxazoles; Oxazoles; Rats; Structure-Activity Relationship | 1979 |
2-aryl-5-benzoxazolealkanoic acid derivatives with notable antiinflammatory activity.
Topics: Animals; Anti-Inflammatory Agents; Carboxylic Acids; Carrageenan; Edema; Female; Lethal Dose 50; Oxazoles; Plethysmography; Rats | 1975 |
Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Body Temperature; Edema; Isoxazoles; Male; Oxazines; Oxazoles; Rats; Salicylates; Stomach Ulcer | 1975 |
[Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug].
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Body Weight; Capillary Permeability; Cyclooxygenase Inhibitors; Edema; Gastric Mucosa; Isoxazoles; Mice; Organ Size; Oxazoles; Platelet Aggregation Inhibitors; Rabbits; Rats | 1990 |
The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin.
Topics: Animals; Drug Hypersensitivity; Edema; Female; Hypersensitivity, Delayed; Kinetics; Mice; Mice, Inbred BALB C; Oxazoles; Oxazolone; Peroxidase | 1990 |
Substituted spiro[isoxazolidine-3,2'-tricyclo[3.3.1.1(3,7)]decane] derivatives.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemical Phenomena; Chemistry; Edema; Isoxazoles; Male; Oxazoles; Rats; Rats, Inbred Strains; Spiro Compounds | 1987 |
Potential biologically active agents. Note II. Synthesis and pharmacological evaluation of some new 3-isoxazolyl-substituted-1,2,3-benzotriazin-4(3H)-ones.
Topics: Animals; Anti-Inflammatory Agents; Chemical Phenomena; Chemistry; Edema; Isoxazoles; Oxazoles; Rats; Rats, Inbred Strains; Triazines | 1985 |
The treatment of endometriosis with Danazol.
Topics: Acne Vulgaris; Adult; Alkynes; Drug Hypersensitivity; Edema; Endometriosis; Female; Gonadotropins; Humans; Hydroxysteroids; Laparoscopy; Laparotomy; Oxazoles; Pituitary Gland; Pregnadienes | 1973 |
Anti-inflammatory properties of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin).
Topics: Airway Obstruction; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Bradykinin; Carrageenan; Dogs; Edema; Emulsions; Encephalomyelitis, Autoimmune, Experimental; Female; Fever; Freund's Adjuvant; Indazoles; Male; Molecular Weight; Mycobacterium; Oxazoles; Peptic Ulcer; Propionates; Rats; Sulfanilamides; Synovitis; Time Factors; Uric Acid; Yeasts | 1974 |
Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395).
Topics: Adjuvants, Immunologic; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Benzoxazines; Blood Pressure; Carrageenan; Diuretics; Edema; Electroencephalography; Gastrointestinal Hemorrhage; Heart Rate; Indomethacin; Male; Oxazines; Oxazoles; Phenylbutazone; Rats; Stomach Ulcer | 1974 |
5-(2-Aminoethyl)-2-oxazolidinones with central nervous system depressant and antiinflammatory activity.
Topics: Aggression; Analgesics; Animals; Anti-Inflammatory Agents; Behavior, Animal; Carrageenan; Central Nervous System; Crowding; Depression, Chemical; Edema; Electroencephalography; Ethylamines; Evoked Potentials; Female; Humans; Mice; Oxazoles; Rats; Structure-Activity Relationship; Tranquilizing Agents | 1973 |
Pharmacological research on 4,5-diphenyl-2-bis(2-hydroxyethyl)-aminoxazol (Ditazol), a new synthetic oxazole derivative as an anti-inflammatory agent.
Topics: Administration, Oral; Administration, Topical; Adrenalectomy; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Temperature; Capillary Permeability; Edema; Ethanolamines; Female; Granuloma; Guanethidine; Hot Temperature; Male; Mice; Oxazoles; Phenylbutazone; Rats; Reserpine; Seizures | 1973 |
Derivatives of 2-aminooxazoles showing antiinflammatory activity.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Arthritis; Central Nervous System; Depression, Chemical; Edema; Injections, Intraperitoneal; Lethal Dose 50; Mice; Oxazoles; Urea | 1971 |
Diaryloxazole and diarylthiazolealkanoic acids: two novel series of non-steroidal anti-inflammatory agents.
Topics: Aldehydes; Animals; Anti-Inflammatory Agents; Aspirin; Biological Assay; Carrageenan; Edema; Gastric Mucosa; Gastrointestinal Hemorrhage; Hot Temperature; Humans; Indomethacin; Oxazoles; Phenylbutazone; Protein Denaturation; Rats; Serum Albumin; Thiazoles | 1968 |